Verified peer comparison
Seres Therapeutics vs ImageneBio Financial Comparison
Direct answer
Seres Therapeutics and ImageneBio are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Seres Therapeutics Revenue
- 789,000 USD
- ImageneBio Revenue
- 800,000 USD
- Seres Therapeutics Operating income
- -93,971,000 USD
- ImageneBio Operating income
- -48,451,000 USD